Lancet
-
Retraction Of Publication
Retraction: Clinical transplantation of a tissue-engineered airway.
-
Retraction Of Publication
Retraction: The first tissue-engineered airway transplantation: 5-year follow-up results.
-
Randomized Controlled Trial Multicenter Study
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial.
Spesolimab is an anti-interleukin-36 receptor monoclonal antibody approved to treat generalised pustular psoriasis (GPP) flares. We aimed to assess the efficacy and safety of spesolimab for GPP flare prevention. ⋯ Boehringer Ingelheim.